Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival.

Donahue, James M

Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. [electronic resource] - The Annals of thoracic surgery Feb 2009 - 392-8; discussion 398-9 p. digital

Publication Type: Journal Article

1552-6259

10.1016/j.athoracsur.2008.11.001 doi


Adenocarcinoma--mortality
Adult
Age Factors
Aged
Aged, 80 and over
Carcinoma, Squamous Cell--mortality
Chemotherapy, Adjuvant
Cohort Studies
Confidence Intervals
Disease-Free Survival
Esophageal Neoplasms--mortality
Esophagectomy--methods
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Preoperative Care--methods
Probability
Prognosis
Radiotherapy, Adjuvant
Retrospective Studies
Risk Assessment
Sex Factors
Survival Analysis
Young Adult